Developed as an antidote to the vesicant warfare agent, dichloro(2-chlorovinyl)arsine, q.v., also known as Lewisite. Inhibits the toxic action of arsenic on pyruvate dehydrogenase. Discovery and development: R. A. Peters et al., Nature 156, 616 (1945); L. L. Waters, C. Stock, Science 102, 601 (1945). Prepn by hydrogenation of hydroxypropylene trisulfide: W. J. Peppel, F. K. Signaigo, US 2402665 (1946 to DuPont). Stereospecific synthesis: A. K. M. Anisuzzaman, L. N. Owen, J. Chem. Soc. C 1967, 1021. GC/MS determn in plasma: C. E. Byers et al., J. Anal. Toxicol. 28, 384 (2004). Toxicity study: P. Zvirblis, R. I. Ellin, Toxicol. Appl. Pharmacol. 36, 297 (1976). Review of discovery, biochemistry and clinical applications: J. A. Vilensky, K. Redman, Ann. Emerg. Med. 41, 378-383 (2003).
Antidote (heavy metal poisoning).
Antidote (Heavy Metal Poisoning)